Q1 Earnings Forecast for GT Biopharma Issued By Roth Capital
GT Biopharma, Inc. (NASDAQ:GTBP – Free Report) – Equities research analysts at Roth Capital dropped their Q1 2025 earnings per share estimates for shares of GT Biopharma in a research note issued on Tuesday, February 25th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings of ($0.64) per share for the […]
